ZOLL Medical Corporation engages in designing, manufacturing, and marketing, and selling noninvasive resuscitation devices and related software solutions in the United States and internationally. The company offers products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation that enable clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. Its products include a range of professional defibrillators, which include M Series, E Series, R Series, and LifeVest wearable defibrillators, which are used by trained healthcare professionals to defibrillate a person in sudden cardiac arrest; automated external defibrillators, such as AED Pro and the AED Plus, which assist with manual CPR efforts; disposable electrodes used with ZOLL's line of defibrillators; the AutoPulse non-invasive cardiac support pump, used to automate the process of delivering chest compressions; documentation and information management products, including RescueNet for EMS personnel and CodeNet for hospitals; and ZOLL Infuser, a fluid replacement product, which provide circulatory support through IV fluid administration. It also offers various single-patient-use proprietary disposable electrodes for use with ZOLL's line of defibrillators and automated external defibrillators. Its international markets primarily comprise Canada, England, Germany, Austria, the Netherlands, France, Australia, and the United Kingdom. The company markets its products primarily to hospitals, emergency medical services, and other players in the public safety market through sales and managerial staff comprised of direct representatives and their managers, distribution managers, special account representatives, distributors, and manufacturer's representatives. ZOLL Medical Corporation was incorporated in 1980 and is headquartered in Chelmsford, Massachusetts.
Full Time Employees: 1,080
Shares Outstanding: 20.39M